Biological Therapy [topp]
Levels [qlco]
Antibodies [aapp, celc, imft]
Phosphorylcholine [orch, phsu]
Apolipoproteins [aapp, bacs]
Rheumatoid Arthritis [dsyn]
Study [mnob]
Objective [inpr]
treatment [ftcn]
Rheumatoid Arthritis [dsyn]
tumor necrosis factor-alpha [aapp, imft]
antagonists [chvf]
TNF [aapp, imft]
B-cell [cell]
Targeting [ftcn]
rituximab [aapp, imft, phsu]
Novel [tmco]
Marker [clna]
Atherosclerosis [dsyn]
Inflammation [patf]
Natural [ftcn]
IgM antibody [celc]
Phosphorylcholine [orch, phsu]
Oxidised low density lipoprotein [aapp, bacs]
Apolipoproteins [aapp, bacs]
Methods [inpr]
Study, Prospective [resa]
Patients [podg]
Rheumatoid Arthritis [dsyn]
Seropositive [qlco]
Aged [orga]
disease duration [tmco]
Patients [podg]
treated [topp]
TNF [aapp, imft]
rituximab [aapp, imft, phsu]
Patients [podg]
Assessed [acty]
Blood [tisu]
sampled [diap]
months [tmco]
IgM antibody [celc]
Natural [ftcn]
Phosphorylcholine [orch, phsu]
Oxidised low density lipoprotein [aapp, bacs]
ELISA [lbpr]
Apolipoproteins [aapp, bacs]
IgM antibody [celc]
Natural [ftcn]
Phosphorylcholine [orch, phsu]
Increased [qnco]
TNF [aapp, imft]
treatment [ftcn]
P NOS [aapp, imft]
Decreased [qnco]
rituximab [aapp, imft, phsu]
P NOS [aapp, imft]
months [tmco]
treatment [ftcn]
Patients [podg]
Remission [fndg]
months [tmco]
baseline [bodm]
Natural [ftcn]
IgM antibody [celc]
Phosphorylcholine [orch, phsu]
Levels [qlco]
Compared [acty]
Remission [fndg]
TNF [aapp, imft]
P NOS [aapp, imft]
rituximab [aapp, imft, phsu]
treated [topp]
Subject [grup]
P NOS [aapp, imft]
treatment [ftcn]
Group [idcn]
Levels [qlco]
Oxidised low density lipoprotein [aapp, bacs]
Increased [qnco]
months [tmco]
Apo A-1 [aapp, bacs]
Improved [qlco]
Study [mnob]
Correlated [qlco]
activity [dora]
Apo-B [aapp, bacs]
Apo-B [aapp, bacs]
Apo A-1 [aapp, bacs]
Ratio [qnco]
Stable [qlco]
Whole [qnco]
Study [mnob]
Conclusions [idcn]
TNF [aapp, imft]
treatment [ftcn]
Favorable [qlco]
Long-Term Effect [phpr]
On [ftcn]
Natural [ftcn]
IgM antibody [celc]
Phosphorylcholine [orch, phsu]
Levels [qlco]
Levels [qlco]
Of [spco]
IgM antibody [celc]
Natural [ftcn]
Phosphorylcholine [orch, phsu]
Immune [ftcn]
Deficient [ftcn]
State [geoa]
Inferior [spco]
therapy [ftcn]
Response [orga]
Therapies, Biological [topp]
Increased [qnco]
Atherogenesis [patf]
Lipid [lipd]
Apo A-1 [aapp, bacs]
IMPACT [gngm]
effects [qlco]
Future [tmco]
CVD, NOS [dsyn]
Events [evnt]
